[1] |
Kim YK,Lee KW,Cho SY, et al. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients[J]. Liver Transpl, 2010, 16(6):767-772.
|
[2] |
Jun L,Zhenlin Y,Renyan G, et al. Independent factors and predictive score for extrahepatic metastasis of hepatocellular carcinoma following curative hepatectomy[J]. Oncologist, 2012, 17(7):963-969.
|
[3] |
Teegen EM,Mogl MT,Pratschke J, et al. Adrenal metastasis of hepatocellular carcinoma in patients following liver resection or liver transplantation: experience from a tertiary referral center[J]. Int J Surg Oncol, 2018:4195076.
|
[4] |
Chok KSh. Management of recurrent hepatocellular carcinoma after liver transplant[J]. World J Hepatol, 2015, 7(8): 1142-1148.
|
[5] |
Wu L,Swan P,McCall J, et al. Intention-to-treat analysis of liver transplantation, resection and thermal ablation for hepatocellular carcinoma in a single centre[J]. HPB, 2018, 20(10):966-976.
|
[6] |
Patkowski W,Stankiewicz R,Grąt M, et al. Poor outcomes after liver transplantation in patients with incidental cholangiocarcinoma irrespective of tumor localization[J]. Transplant Proc, 2014, 46(8): 2774-2776.
|
[7] |
Fernandez-Sevilla E,Allard MA,Selten J, et al. Recurrence of hepatocellular carcinoma after liver transplantation: is there a place for resection?[J]. Liver Transpl, 2017, 23(4):440-447.
|
[8] |
Sneag DB,Krajewski K,Giardino A, et al. Extrahepatic spread of hepatocellular carcinoma: spectrum of imaging findings[J]. AJR Am J Roentgenol, 2011, 197(4):W658-664.
|
[9] |
Liu D,Chan AC,Fong DY, et al. Evidence-based surveillance imaging schedule after liver transplantation for hepatocellular carcinoma recurrence[J]. Transplantation, 2017, 101(1):107-111.
|
[10] |
曾婕,郑荣琴,任杰,等.肝移植术后肝癌复发的二维超声及超声造影表现[J/CD].中华医学超声杂志(电子版),2010, 7(4): 666-670.
|
[11] |
Girometti R,Como G,Bazzocchi M, et al. Post-operative imaging in liver transplantation: state-of-the-art and future perspectives[J]. World J Gastroenterol, 2014, 20(20):6180-6200.
|
[12] |
Shi G,Wang C,Zhang P, et al. Donor polymorphisms of toll-like receptor 4 rs1927914 associated with the risk of hepatocellular carcinoma recurrence following liver transplantation[J]. Arch Med Res, 2017, 48(6):553-560.
|
[13] |
Chiorean L,Tana C,Braden B, et al. Advantages and limitations of focal liver lesion assessment with ultrasound contrast agents: comments on the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines[J]. Med Princ Pract, 2016, 25(5):399-407.
|
[14] |
Wan P,Xia Q,Zhang JJ, et al. Liver transplantation for hepatocellular carcinoma exceeding the Milan criteria: a single-center experience[J]. J Cancer Res Clin Oncol, 2014, 140(2):341-348.
|
[15] |
Sharma P,Welch K,Hussain H, et al. Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era[J]. Dig Dis Sci, 2012, 57(3):806-812.
|
[16] |
刘子荣,张雅敏.肝癌肝移植术后复发转移的防治与评估[J].中华肝胆外科杂志,2018, 24(6):424-426.
|
[17] |
Lu D,Zhuo J,Yang M, et al. The association between donor genetic variations in one-carbon metabolism pathway genes and hepatitis B recurrence after liver transplantation[J]. Gene, 2018(663): 121-125.
|
[18] |
任秀昀,李春伶,徐惠,等.肝细胞癌肝移植术后肝内复发灶的超声造影参数成像分析[J].中华超声影像学杂志,2012, 21(10): 864-867.
|
[19] |
Sidhu PS,Cantisani V,Dietrich CF, et al. The EFSUMB Guidelines and Recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version)[J]. Ultraschall Med, 2018, 39(2):e2-44.
|
[20] |
Jin Y,He YS,Zhang MM, et al. Value of contrast-enhanced ultrasonography in the differential diagnosis of enlarged lymph nodes: a meta-analysis of diagnostic accuracy studies[J]. Asian Pac J Cancer Prev, 2015, 16(6):2361-2368.
|